Folic Acid (Vitamin B9, Folate, Folacin)

Continue reading “Folic Acid (Vitamin B9, Folate, Folacin)”

Advertisements

Pharmacology News Digest, July 15th

Continue reading “Pharmacology News Digest, July 15th”

Pharmacology News Round-Up | July 6th, 2018

Continue reading “Pharmacology News Round-Up | July 6th, 2018”

Pharmacology News Round-Up: June 21st, 2018

This week’s clinical pharmacology highlights include advances in cancer therapy, long-term followup of the landmark PROACT trial comparing anticoagulation strategies after aortic replacement, and the finding that hydrocortisone may not reduce mortality in septic shock.

Continue reading “Pharmacology News Round-Up: June 21st, 2018”

Moxidectin, First New Treatment for River Blindness in 30 Years, Approved by FDA

The US FDA has approved the antihelminthic drug moxidectin (developed by Medicines Development for Global Health) for the treatment of onchocerciasis.¹

Merck’s ivermectin, developed in the late 1970s, is the only other pharmaceutical agent approved for treating onchocerciasis.  Moxidectin has outperformed ivermectin in clinical trials, demonstrating superior efficacy and comparable safety. Continue reading “Moxidectin, First New Treatment for River Blindness in 30 Years, Approved by FDA”

Weekly Pharmacology News Round-Up: June 8th – June 14th 2018

This week’s clinical pharmacology highlights include a new treatment for river blindness, further success for JAK inhibitors in inflammatory diseases, and the finding that more patients are taking medications associated with depressive symptoms.

Continue reading “Weekly Pharmacology News Round-Up: June 8th – June 14th 2018”